CIK 0000728387
- Non-accelerated filer
- Smaller reporting company
Perspective Therapeutics, Inc.
Sign in to watch- Ticker
- CATX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 411458152
- Phone
- +1 206-676-0900
- Business address
- 2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
- Former names
- IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
- 4 Open-market buy Director bought 10,000 shares at $1.66 ($16,600)
- 4 Open-market buy Director bought 10,000 shares at $1.80 ($17,999)
- 4 Open-market buy CEO bought 10,029 shares at $1.51 ($15,144)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Vice President sold 50,000 shares at an average $2.41 ($120,310)
- 4/A Open-market sale Vice President sold 30,571 shares at $2.22 ($67,868)
- 4 Open-market sale Vice President sold 30,571 shares at $2.22 ($67,868)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy CEO bought 25,000 shares at $0.53 ($13,250)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 18,100 shares at $0.49 ($8,869)
- 4 Open-market buy CEO bought 10,100 shares at an average $0.40 ($4,039)
- 4 Open-market buy CEO bought 4,800 shares at $0.37 ($1,776)
- 4 Open-market buy CEO bought 35,100 shares at an average $0.42 ($14,787)
- 4 Open-market buy Director bought 25,000 shares at $0.38 ($9,500)
- 4 Open-market sale Controller sold 11,334 shares at an average $0.99 ($11,221)
Page 12 of 18 · 341 filings